drugset / Trial / NCT04221919
Different β -Blockers in STEMI and Primary PCI
RandomizedParallel-groupTriple-blindTreatment
Summary
Carvedilol, target dose: 50 mg daily; Bisoprolol, target dose: 10 mg daily; Metoprolol tartrate, target dose: 150 mg daily; Metroprolol succinate, target dose: 200 mg daily
Timeline
- Start
- 2020-01
- Primary completion
- 2021-01
- Completion
- 2025-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bisoprolol | Other / unclassified | 10 mg | — |
| Subject | Carvedilol | Other / unclassified | 50 mg | — |
| Subject | Digoxin | Other / unclassified | 200 mg | — |
| Subject | Metoprolol | Other / unclassified | 150 mg | — |